Agendia touts MammaPrint clinical results
June 7, 2021 -- Agendia is highlighting research shared at the virtual 2021 American Society of Clinical Oncology meeting that shows its MammaPrint 70-gene signature test accurately identifies indolent, low-risk breast cancers. Read More
Sysmex Inostics touts liquid biopsy findings at ASCO
June 4, 2021 -- Sysmex Inostics will present a poster on a liquid biopsy assay at the American Society of Clinical Oncology (ASCO) virtual annual meeting. Read More
Sophia launches blood cancer testing platform
June 3, 2021 -- Sophia Genetics announced it has released new software for testing relevant DNA variants and RNA fusion genes involved in blood cancers. Read More
Millennium Technology Prize awarded to NGS pioneers
May 20, 2021 -- The Technology Academy Finland awarded the 2020 Millennium Technology Prize to Shankar Balasubramanian, PhD, and David Klenerman, PhD, chemists from Cambridge University, for the development of Solexa-Illumina next-generation sequencing (NGS) technology. Read More
Illumina donates $60M in NGS tools to build genomic network
April 28, 2021 -- Illumina is donating $60 million in next-generation sequencing (NGS) platforms, reagents, and support to create a comprehensive pathogen genomic network in South Asia. Read More
Variantyx obtains $20M in funding
March 16, 2021 -- Hereditary disease testing provider Variantyx has obtained $20M in funding for its whole genome sequencing-based testing method. Read More
Vela Diagnostics adds 2 SARS-CoV-2 assays
February 26, 2021 -- Vela Diagnostics has added two SARS-CoV-2 assays to its portfolio: ViroKey SQ Flex SARS-CoV-2 genotyping and ViroKey SARS-CoV-2 ID reverse transcription polymerase chain reaction. Read More
Qiagen, Inovio to partner on cervical dysplasia test
February 24, 2021 -- Qiagen and Inovio have announced they will develop a next-generation sequencing test for HPV-linked advanced cervical dysplasia that can be used on Illumina's NextSeq 550Dx platform. Read More
Illumina partners with German university on genome sequencing
February 19, 2021 -- Illumina is joining forces with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen in Germany on whole-genome sequencing. The two will evaluate WGS as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Read More
Variantyx debuts whole genome sequencing prenatal test
January 27, 2021 -- Hereditary disease testing provider Variantyx has entered the women's health market with the launch of its Genomic Unity Prenatal Analysis test at this week's Society for Maternal Fetal Medicine's 41st Annual Pregnancy Meeting. Read More